Your browser doesn't support javascript.
loading
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells.
Miyauchi, Kosuke; Adachi, Yu; Tonouchi, Keisuke; Yajima, Taiki; Harada, Yasuyo; Fukuyama, Hidehiro; Deno, Senka; Iwakura, Yoichiro; Yoshimura, Akihiko; Hasegawa, Hideki; Yugi, Katsuyuki; Fujii, Shin-Ichiro; Ohara, Osamu; Takahashi, Yoshimasa; Kubo, Masato.
Afiliación
  • Miyauchi K; Laboratory for Cytokine Regulation, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
  • Adachi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tonouchi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yajima T; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan.
  • Harada Y; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan.
  • Fukuyama H; Laboratory for Lymphocyte Differentiation, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
  • Deno S; Laboratory for Integrated Cellular Systems, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
  • Iwakura Y; Institute for Advanced Biosciences, Keio University, Kanagawa, Fujisawa, Japan.
  • Yoshimura A; Systems Biology Program, Graduate School of Media and Governance, Keio University, Kanagawa, Fujisawa, Japan.
  • Hasegawa H; Center for Animal Disease Models, Research Institute for Biomedical Science, Tokyo University of Science, Chiba, Japan.
  • Yugi K; Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
  • Fujii SI; Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ohara O; Laboratory for Integrated Cellular Systems, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
  • Takahashi Y; Institute for Advanced Biosciences, Keio University, Kanagawa, Fujisawa, Japan.
  • Kubo M; Laboratory for Immunotherapy, Research Center for Integrative Medical Sciences (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
Nat Commun ; 12(1): 3789, 2021 06 18.
Article en En | MEDLINE | ID: mdl-34145279
ABSTRACT
Influenza viruses are a major public health problem. Vaccines are the best available countermeasure to induce effective immunity against infection with seasonal influenza viruses; however, the breadth of antibody responses in infection versus vaccination is quite different. Here, we show that nasal infection controls two sequential processes to induce neutralizing IgG antibodies recognizing the hemagglutinin (HA) of heterotypic strains. The first is viral replication in the lung, which facilitates exposure of shared epitopes that are otherwise hidden from the immune system. The second process is the germinal center (GC) response, in particular, IL-4 derived from follicular helper T cells has an essential role in the expansion of rare GC-B cells recognizing the shared epitopes. Therefore, the combination of exposure of the shared epitopes and efficient proliferation of GC-B cells is critical for generating broadly-protective antibodies. These observations provide insight into mechanisms promoting broad protection from virus infection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos B / Interleucina-4 / Infecciones por Orthomyxoviridae / Anticuerpos ampliamente neutralizantes / Hemaglutininas Virales / Anticuerpos Antivirales Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos B / Interleucina-4 / Infecciones por Orthomyxoviridae / Anticuerpos ampliamente neutralizantes / Hemaglutininas Virales / Anticuerpos Antivirales Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Japón